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Editorial
Misconceptions and ill-founded theories can arise in all areas of science. However, the apparent accessibility of many epidemiology
findings and popular interest in the subject can lead to additional misunderstandings. The article below is the fourth in an occasional
series of short editorials highlighting some current misinterpretations of epidemiological findings. Invited authors will be given wide
scope in judging the prevalence of the misconception under discussion. We hope that this series will prove instructive to cancer
researchers in other disciplines, as well as to students of epidemiology.
Adrian L Harris and Leo Kinlen
That the effects of smoking should be measured in pack-years:
misconceptions 4
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Lung cancer incidence in smokers is roughly proportional to dose rate (cigarettes per day) but increases much more rapidly with
duration of smoking. The assumption that the incidence rate is proportional to total lifetime dose (the product of dose rate and
duration) has been known to be wrong for many years, but total dose in pack-years is still often included, either alone or together,
with more fundamental parameters such as dose rate, in regression analysis of epidemiological data. This is mathematically
unnecessary and scientifically unhelpful.
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The dose rate and duration of exposure to a carcinogen are often
combined to give a single measure of lifetime cumulative dose,
despite long-standing evidence that cancer risk at a given
cumulative dose sometimes varies substantially with the duration
of exposure. An example is radon-induced lung cancer, where the
risk per working-level month increases sharply with increasing
duration (Darby and Doll, 1990). Another example is the
widespread practice of summarising smoking history as ‘pack-
years’ (the product of duration and smoking rate), which is
inconsistent with an old and remarkably simple model that
describes lung cancer incidence reasonably well. The incidence
rate is approximately proportional to the fourth power of age in
non-smokers, and the excess in smokers is proportional to the
fourth power of smoking duration multiplied by the number of
cigarettes smoked per day (Doll, 1978). Table 1 shows the age-
specific patterns predicted by this formula for the incidence rate in
non-smokers, and for the excess incidence rate in smokers who
began smoking at age 15. (The annual incidence rates in Table 1
are standardised to give a rate at age 60 of 13 per 100 000 in non-
smokers and 300 per 100 000 in smokers of one pack per day.)
When smoking ceases the incidence rate stops increasing and
remains almost constant for more than a decade before rising
slightly (Peto, 2011), so this model also describes the rate in ex-
smokers fairly well.
The model has several important implications for biological
models of carcinogenesis: (1) Ageing per se is irrelevant to lung
carcinogenesis. The excess in smokers increases from the time
when smoking begins, independent of age, suggesting that
smoking initiates the process. The rate in non-smokers increases
from birth in the same pattern (although much less rapidly),
suggesting a similar mechanism because of random somatic
damage that occurs at a constant rate throughout life. (2) The lung
cancer incidence rate remains roughly constant when smoking
ceases. This suggests that smoking also acts at a late stage in
carcinogenesis, but as the rate does not fall when smoking ceases it
seems that the final event that a cell must undergo to become fully
malignant is unaffected by smoking. (3) The effect of smoking rate
appears to include a quadratic component (Doll, 1978), consistent
with the inference that smoking acts both early and late in
multistage carcinogenesis. (4) The power of duration (four) is
higher than the power of smoking rate (one or two), suggesting
Table 1 Predicted lung cancer incidence rates per 100 000 per year in
non-smokers (NS), and excess incidence rates (ES) and excess relative risks
(ERR) in smokers of 1 pack per day from age 15
Incidence
in non-
smokers
Excess
incidence
in smokers Pack-years
Excess
rel risk
ERR
per pack-
year
Age
NS
Age4
ES
(Age 15)4
P
(Age15)
ERR¼
ES/NS ERR/P
30 0.8 3.7 15 4.6 0.30
40 2.6 28.6 25 11.1 0.45
50 6.3 109.8 35 17.5 0.50
60 13.0 300.0 45 23.1 0.51
70 24.1 669.5 55 27.8 0.51
80 41.1 1305.9 65 31.8 0.49
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that there are additional rate-limiting steps in carcinogenesis that
are independent of smoking. (5) The effects of dose rate and
duration are statistically independent.
These important insights about carcinogenesis have been
obscured by two unfortunate developments in epidemiological
analysis. First, it is easier to model relative rather than absolute
risks, particularly in case–control studies. Dividing by the rate in
non-smokers to calculate relative risks obscures the underlying
pattern of lung cancer incidence in smokers, which in continuing
smokers increases with age more steeply than in non-smokers but
remains almost constant after smoking has ceased. Second, the
effect of smoking history is often modelled by fitting pack-years
rather than including the duration and dose rate as separate
variables. This is a serious error, as the excess incidence for
20 pack-years is much greater after 40 years of smoking 0.5 packs
per day (404 0.5) than for 10 years at 2 packs per day (104 2).
The effect of smoking is trivial for the first decade but substan-
tial after 40 years, so the relative risk (the smoker : non-smoker
incidence ratio) increases sharply with age in continuing smokers,
although in ex-smokers it falls. Pack-years also rises sharply
with age in continuing smokers, however, so their excess relative
risk (ERR) per pack-year is almost independent of age. These
effects are illustrated in Table 1, which is based on the simplified
model described above. In smokers aged over 40 who began
smoking around age 15, the ERR per pack-year is virtually
independent of age. This is a consequence of the fact that smoking
typically begins at around age 15, and the meaningless arithmetical
accident that the ERR per pack-year, which is then (Age 15)3/
(Age)4, happens to be fairly constant above age 40, which is the
youngest age at which lung cancer is common enough to be
studied.
A careful analysis of the deviations from the simplified model
described above and explicit alternative models are needed to
advance our understanding of carcinogenesis. For example, age
(or age at starting to smoke) may have some independent role in
addition to smoking duration (Moolgavkar et al, 1989). This could
be due to artefacts such as trends in tar level, or age-related
changes in amount smoked leading to errors in estimated dose in
both prospective and case–control studies. If true, however, it
would suggest a promoting effect on cells that were initiated spon-
taneously before smoking began, which is a plausible extension of
the model. Science advances by developing and testing plausible
models, not by regression analysis of gross deviations from models
that are clearly wrong. Lung cancer risk is not proportional to
pack-years, so complex modelling of the variation in ERR per
pack-year in relation to more fundamental variables such as smoking
rate (Lubin et al, 2007) is unlikely to be biologically informative.
The mechanistic insights and hypotheses from pre-molecular
cancer epidemiology (Doll, 1978) may soon be testable, but
they are in danger of being forgotten just as the genetic
events that underlie such patterns are being discovered
(Pleasance et al, 2010).
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